Publications

Li S, Wang Z, Wu Z, Zhuang H, Xu Y. Clinical characteristics and outcomes of primary adrenal diffuse large B cell lymphoma in a large contemporary cohort: a SEER-based analysis. Ann Hematol 2019; 98(9):2111-2119.

Li S, Wang Z, Lin L, Wu Z, Yu Q, Gao F, Zhang J, Xu Y. BCL6 Rearrangement Indicates Poor Prognosis in Diffuse Large B-cell Lymphoma Patients: A Meta-analysis of Cohort Studies. J Cancer. 2019 Jan 1;10(2):530-538.

He X, Zhu Y, Lin YC, et al. PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD+ acute myeloid leukemia. Blood. 2019;134(6):548-560.

Tong J, Hu R, Zhao Y, Xu Y, Zhao X, Jin X. Serum Vitamin A Levels May Affect the Severity of Ocular Graft-versus-Host Disease. Front Med (Lausanne). 2017; 4:67.

Gu Y, Zhang J, Ma X, et al. Stabilization of the c-Myc Protein by CAMKIIγ Promotes T Cell Lymphoma. Cancer Cell. 2017; 32:115-128.

Liang Y, Gao J, Wu D, Li S, Chen H, Ding L, Tong J, Xu Y. Long-term remission following autologous hematopoietic cell transplantation in a patient with multiple nonleukemic myeloid sarcoma and a review of the literature. Acta Haematol 2017; 137:117-122.

Xiao Y, Yu S, Xu Y. The prevalence and biochemical profiles of EDTA-dependent pseudothrombocytopenia in a generally healthy population. Acta Haematol 2015; 134:177-180.

Xiao Y, Xu Y Concomitant spuriously elevated white blood cell count, a previously underestimated phenomenon in EDTA-dependent pseudothrombocytopenia. Platelets. 2015; 26:627-631.

Xu Y, Liu Z, Sun J, Pan Q, Sun F, Yan Z, Hu X. Schisandrin B prevents doxorubicin-induced chronic cardiotoxicity and enhances its anticancer activity in vivo. PLoS One. 2011, 6: e28335.

Xu Y, Yan W，Chen X. SNF5, a core component of the SWI/SNF complex, is necessary for p53 expression and cell survival, in part through eIF4E. Oncogene 2010, 29: 4090-4100.

Xu Y, Zhang J, Chen X. The transcriptional activity of p53 is differentially regulated by Brg1and Brm-containing SWI/SNF chromatin remodeling complexes. J Biol Chem. 2007; 282: 37429-37435.

Xu Y, Chen X. Glyoxalase II, a detoxifying enzyme of glycolysis byproduct methylglyoxal and a target of p63 and p73, is a pro-survival factor of the p53 family. J Biol Chem. 2006; 281: 26702-26713.